02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

476A AASLD ABSTRACTS HEPATOLOGY, October, 2015<br />

The following authors have nothing to disclose: Maria Stepanova, Sarah Elfeky,<br />

Alexandrea Srishord, Carey Escheik, Leo Mclaughlin, Mariam Afendy, Robert J.<br />

Wong, Sharon L. Hunt<br />

535<br />

A New Approach to Patient Centered Care in Hepatology:<br />

Patient Reported Outcomes Assessment<br />

Manisha Verma 1 , Victor J. Navarro 1 , Shana D. Stites 2 , Eyob L.<br />

Feyssa 1 , Simona Rossi 1 ; 1 Hepatology, Einstein Healthcare Network,<br />

Philadelphia, PA; 2 Center for Urban Health, Einstein Healthcare<br />

Network, Philadelphia, PA<br />

Background: Patient Reported Outcomes (PRO) are measures of<br />

symptoms, health behavior &/or experiences reported directly<br />

by patients. Integrating PRO Assessment (PA) in routine care<br />

improves patient centered care (PCC). PROMIS-29 (Patient<br />

Reported Outcomes Measurement Information System) is a<br />

web-based NIH supported validated set of 29 questions used<br />

for PA. Our aim is to identify if PA influences PCC in patients<br />

with cirrhosis, through enhanced communication, & facilitating<br />

detection of physical/ psychological issues. Methods: This is<br />

a prospective nonrandomized study of the feasibility, acceptability,<br />

& clinical value of PA in cirrhotics. PA included 1)<br />

provider training in PA score interpretation, 2) administering<br />

PROMIS-29, & 3) reporting PA results (T-scores) to patients &<br />

providers for point of care use. T-score measures the symptom<br />

assessed. Higher scores reflect greater symptom assessed. All<br />

outpatients with cirrhosis were eligible. Patient and provider<br />

feedback surveys were administered after each visit to assess<br />

acceptability/feasibility. Descriptive statistics were used to<br />

assess baseline measures; paired t-tests were used to compare<br />

baseline and 3 month data. Results: 50 patients were enrolled;<br />

3 month data were available for 20. There were no statistically<br />

significant differences in baseline measures based on<br />

gender, race, or duration of liver disease (p>0.05). At baseline,<br />

pain, anxiety, & fatigue were worse in our sample vs the<br />

US population (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!